Drug Shortage Report for CELECOXIB
| Report ID | 247534 |
| Drug Identification Number | 02436299 |
| Brand name | CELECOXIB |
| Common or Proper name | CELECOXIB |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CELECOXIB |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | M01AH |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-02-14 |
| Actual start date | |
| Estimated end date | 2025-03-14 |
| Actual end date | 2025-02-10 |
| Shortage status | Avoided shortage |
| Updated date | 2025-02-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-02-10 | French | Compare |
| v5 | 2025-02-10 | English | Compare |
| v4 | 2025-01-22 | French | Compare |
| v3 | 2025-01-22 | English | Compare |
| v2 | 2025-01-13 | French | Compare |
| v1 | 2025-01-13 | English | Compare |
Showing 1 to 6 of 6